The Changing Landscape and Advances in the Treatment of Multiple Myeloma (APAC)
We will outline the overview of the current treatments available for multiple myeloma including the loss of market exclusivity for key products in the space. We will also discuss the latest research and innovations that are driving new treatments to help improve patient outcomes in multiple myeloma, including the debate over the risk of secondary malignancies from cell therapy.
Speakers
Sam Fazeli
Head of EMEA Research
Bloomberg
Dr. Andrew Yee
Clinical Director, Center for Multiple Myeloma
Massachusetts General Hospital, Education Center
Andrew Yee, MD, is an Assistant Professor of Medicine at Harvard Medical School (07/2007 - Present) and is Clinical Director at the Center for Multiple Myeloma at Massachusetts General Hospital Cancer Center (07/2007 - Present) His clinical and research focus is multiple myeloma and related conditions; he actively sees patients as their primary oncologist or consultant. He is the principal investigator of several trials for patients with relapsed multiple myeloma.